These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7985051)

  • 1. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
    García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
    Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by retinoic acid of the growth of bone marrow cell progenitors from patients with myelodysplastic syndrome.
    De Francesco A; Sanavio F; Stacchini A; Piacibello W; Quaglino D; Aglietta M
    Haematologica; 1989; 74(1):25-8. PubMed ID: 2498179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.
    Invernizzi R; Pecci A; Rossi G; Pelizzari AM; Giusto M; Tinelli C; Ascari E
    Haematologica; 1997; 82(6):660-3. PubMed ID: 9499664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.
    Invernizzi R; Pecci A; Rossi G; Pelizzari AM; Giusto M; Tinelli C; Ascari E
    Haematologica; 1997; 82(5 Suppl):9-12. PubMed ID: 9402747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
    Nagler A; Rikilis I; Tatarsky I; Fabian I
    J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome: follow-up of 60 cases].
    Guan M; Chen SC; Ge CW
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):919-22. PubMed ID: 19671296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns.
    Nagler A; Riklis I; Kletter Y; Tatarsky I; Fabian I
    Exp Hematol; 1986 Jan; 14(1):60-5. PubMed ID: 3510890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
    Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro hemopoiesis of marrow cells from myelodysplastic patients: effects of mitogen-stimulated spleen cell-conditioned medium and vitamin A and D derivatives.
    Fabian I; Riklis I; Tatarsky I; Nagler A
    Cancer Res; 1986 May; 46(5):2596-9. PubMed ID: 3697999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F; Hao Y; Pang W
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes.
    Swanson G; Picozzi V; Morgan R; Hecht F; Greenberg P
    Blood; 1986 Apr; 67(4):1154-61. PubMed ID: 3513868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of small doses cytosine arabinoside (Ara-C) on leukemic cells in vitro and in vivo. Results in patients with leukemia and myelodysplastic syndrome.
    Kuliczkowski K; Kotlerek-Haus S; Frydecka I; Sedek K; Nowicka J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):738-48. PubMed ID: 2436986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
    Hiçsönmez G; Tuncer AM; Sayli T; Güler E; Cetin M; Ozbek N; Mufti GJ
    Hematol Pathol; 1995; 9(3-4):185-93. PubMed ID: 8655463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification].
    Piguet D; Schmidt PM; Delacrétaz F; Mermillod B
    Schweiz Med Wochenschr; 1987 Jan; 117(2):61-6. PubMed ID: 3468610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Culture of cells forming granulomonocytic colonies in bone marrow (GM-CFU) in myelodysplastic syndromes and their relation to hematological findings and FAB subtype].
    García M; Sanz GF; Arriaga F; Pérez-Sirvent ML; Marty ML; Sanz MA
    Sangre (Barc); 1991 Aug; 36(4):269-75. PubMed ID: 1776105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studies.
    Catalano L; Selleri C; Califano C; Luciano L; Volpicelli M; Rocco S; Varriale G; Ricci P; Rotoli B
    Haematologica; 2000 Feb; 85(2):133-8. PubMed ID: 10681719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new retinoidal benzoic acid derivative on normal human hematopoietic progenitor cell growth in vitro.
    Fabian I; Shvartzmayer S
    Cancer Res; 1986 May; 46(5):2413-5. PubMed ID: 3697984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
    Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
    Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.